Publication|Articles|May 16, 2025
- Pharmaceutical Executive: May 2025
- Volume 45
- Issue 4
Pharmaceutical Executive: May 2025 Interactive Digital Edition
View the Pharmaceutical Executive May 2025 issue in an interactive format.
Advertisement
Articles in this issue
over 1 year ago
Your Voice Boxover 1 year ago
Pharm Exec's 2025 State of the Industry Surveyover 1 year ago
Reshema Kemps-Polanco: Taking Risks for Greater Rewardover 1 year ago
Earned Media and ASCO: Provide Context Beyond the Dataover 1 year ago
How Does the Shift to Early-Stage M&A Change Due Diligence?over 1 year ago
The Three Pillars of Pharma’s New Commercial Modelover 1 year ago
Revenue Optimization: The Money Matters—That Matter Mostover 1 year ago
Bridging the Gap: A Large Pharma BlueprintAdvertisement
Advertisement
Advertisement
Trending on PharmExec
1
Trump Administration Preparing New Round of Medicaid Drug-Pricing Deals: Report
2
FDA Approves Lisraya for Adults with Dermatomyositis, Bixlenvo for Virologically Suppressed Adults with HIV, Mounjaro to Reduce MACE in Adults with Type 2 Diabetes
3
Pharmaceutical Executive Daily: DualityBio and Teva Strike Major Biopharma Deals
4
M&A Roundup: DualityBio & Genentech Enter Partnership to Develop Next Generation ADC’s, Teva Bids to Acquire Igalmi from BioXcel
5